How many missed the $DDD, $SSYS, $PRLB, $XONE run when we had a chance to buy in mid-March but didn’t?

$ONVO, a biotech 3D, has recently been uplisted to NYSE; therefore, it is no longer an OTC bulletin board stock.  This mean all the big guys (institutional and mutual funds holders) can now buy this stock.

$ONVO has two beta-risks lumped together- biotech and new technology.  If this technology and biotech show any hint of proof of concept to create 3D human organ parts for replacing our diseased organs, this company will leave $DDD, $SSYS, etc in the dust.  On the other hand, be prepared for further dilution from secondary offering when money run out in the future.

I believe the weekly chart below is sufficed to show you the breakout pattern.

I bought some today and added more when price continued higher.

My 2 cents.

Comments »